期刊文献+

己酮可可碱对NOD小鼠1型糖尿病的影响 被引量:5

Effect of Pentoxifylline on type 1 diabetes in NOD mice
原文传递
导出
摘要 目的 探讨己酮可可碱 (pentoxifyline ,PTX)对NOD(non obesediabetic)小鼠 1型糖尿病的影响及其机制。方法 采用动物模型NOD鼠 ,PTX处理后检测血糖、尿糖及糖尿病发病率 ,HE染色观察胰岛炎 ,并用RT PCR法检测胰腺干扰素γ(IFN γ)、肿瘤坏死因子α(TNF α)、白介素 10 (IL 10 )mRNA的表达。结果 PTX组糖尿病发生率 (30 .0 % )低于对照组 (6 7.9% ) ,P <0 .0 1;胰岛炎程度也减轻P <0 .0 0 1;胰腺IFN γ、TNF αmRNA的表达较对照组降低 ,P <0 .0 5 ;3项变化均具显著性。而IL 10mRNA的表达则无显著改变。结论 PTX可预防NOD小鼠发生糖尿病 ,其机制可能与纠正Th1与Th2型细胞因子比例失衡有关。 Objective To study the effect of phosphodiesterase inhibitor pentoxifylline (PTX) on type 1 diabetes in NOD mice and its possible mechanism.Methods Blood glucose, urinary glucose, insulitis and incidence of diabetes were investigated in NOD mice treated with PTX, insulitis was observed by HE staining and the expressions of IFN γ, TNF α, IL 10 in pancreas were measured by RT PCR technique. Results The incidence of diabetes in the PTX group was 30.0% which was significantly lower than 67.9% in the control group (P<0.01), and the degree of insulitis in the PTX group was also less than that in the control group (P<0.001). IFN γ and TNF α mRNA expressions in pancreas of PTX group were significantly downregulated (P<0.05) and IL 10 mRNA expression was unaffected as compared with the control group. Conclusion PTX prevents NOD mice from developing type 1 diabetes, which may be related to regulating Th1/Th2 cytokines imbalance.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2002年第5期388-390,共3页 Chinese Journal of Endocrinology and Metabolism
基金 山西省回国留学人员科研资助项目资助 (99 94)
关键词 1型糖尿病 己酮可可碱 近交NOD 干扰素Ⅱ 肿瘤坏死因子 白细胞介素10 动物模型 Pentoxifylline Mice, inbred NOD Diabetes mellitus, insulin dependent Interferon type Ⅱ (Interferon γ) Tumor necrosis factors Interleukin 10
  • 相关文献

参考文献10

  • 1Rott O,Cash E,Fleischer B.Phosphodiesterase inhibitor Pentoxifylline, a selective suppressor of T helper type 1-but not 2 associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats[].European Journal of Immunology.1993 被引量:1
  • 2Liang L,Beshay E.The phosphodiesterase inhibitors Pentoxifylline and Rolipram prevent diabetes in NOD mice[].Diabetes.1998 被引量:1
  • 3Sai P,Rivereau AS,Granier C,et al.Immunization of nonobese diabetic (NOD) mice with glutamic acid decarbosylase-derived peptide 524-543 reduces cyclophosphamide-accelerated diabetes[].Clinical and Experimental Immunology.1996 被引量:1
  • 4Chomczynski P,Sacchi N.Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction[].Analytical Biochemistry.1987 被引量:1
  • 5Han CW,Imamura M,Hashion S,et al.Differential effects of the immunosuppressants cyclosporin A, FK506 and KM2210 on cytokine gene expression[].Bone Marrow Transplantation.1995 被引量:1
  • 6Mary E,Pauza H,Neal A,et al.T-cell production of an inducible interleukin-10 transgene provides limited protection from autoimmune diabetes[].Diabetes.1999 被引量:1
  • 7Roland T.Insulin-dependent diabetes mellitus[].Cell.1996 被引量:1
  • 8Rabinovitch A.Immunoregulatory and cytokine imbalance on the pathogenesis of IDDM[].Diabetes.1994 被引量:1
  • 9Novak TJ,Rothenberg EV.cAMP inhibits induction of interleukin-2 but not of interleukin-4 in T-cells[].Proceedings of the National Academy of Sciences of the United States of America.1990 被引量:1
  • 10Luis R.Phosphodiesterase inhibitor Pentoxifylline: An anti-inflammatory immunomodulatory drug potentially useful in some rheumatic disease[].Rheumatology.1995 被引量:1

同被引文献50

  • 1Liang L, Beshay E, Prud'homme G. The phosphodiesterase inhibitors pentoxifylline and rolipram prevent diabetes in NOD mice. Diabetes, 1998,47:570-575. 被引量:1
  • 2Charlton B, Bacelj A, Slattery RM, et al. Cyclophosphamide-induced diabetes in NOD/WEHI mice. Diabetes, 1989,38:441-447. 被引量:1
  • 3Brode S, Raine T, Zaccone P J, et al. Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4 +CD25 +Foxp3 + regulatory T cells. Immunology, 2006,177:6603- 6612. 被引量:1
  • 4Nakayama M, Nagata M, Yasuda H, et al. Fas/Fas ligand interactions play an essential role in the initiation of murine autoimmune diabetes. Diabetes, 2002,51:1391-1397. 被引量:1
  • 5Maedler K, Spinas GA, Lehmann R, et al. Glucose induces beta-cell apoptosis via upregulation of the Fas receptor in human islets. Diabetes, 2001,50 : 1683-1690. 被引量:1
  • 6Augstein P, Bahr J, Wachlin G, et al. Cytokines activate caspase-3 in insulinoma cells of diabetes-prone NOD mice directly and via upregulation of Fas. J Autoimmun, 2004,23 : 301-309. 被引量:1
  • 7Amrani A, Verdaguer J, Thiessen S, et al. IL-1alpha, IL-1beta, and IFN-gamma mark beta cells for Fas-dependent destruction by diabetogenic CD4( + ) T lymphocytes. J Clin Invest, 2000,105:459- 468. 被引量:1
  • 8Liang L, Beshay E, Poud' homme GJ, et al. The Phosphodiesterase Inhibitors Pentoxifylline and Rolipram Prevent Diabetes in NOD Mice. Diabetes, 1998, 47:570~575. 被引量:1
  • 9Beshay E, Prud' homme GJ. Inhibitors of phosphodiesterase Isoforms Ⅲ or Ⅳ suppresss Islet-cell Nitric Oxide Production.Lab Invest, 2001, 81(8):1109~1117. 被引量:1
  • 10Zhang ZL, Shen Sx, Lin B,et al. Intramuscular injection of interleukin -10 plasmid DNA prevented autoimmune diabetes in mice. Acta Pharmacol Sin, 2003, 24(8): 751~756. 被引量:1

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部